Next Financial Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Next Financial Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$781K	Buy	7,243 +1,331	+23%	+$145K	0.05%	380
2021 Q3	$648K	Buy	5,912 +80	+1%	+$8.3K	0.05%	373
2021 Q2	$546K	Buy	5,832 +67	+1%	+$6.17K	0.04%	429
2021 Q1	$531K	Buy	5,765 +87	+2%	+$7.34K	0.05%	401
2020 Q4	$415K	Sell	5,678 -165	-3%	-$12.3K	0.04%	441
2020 Q3	$454K	Buy	5,843 +74	+1%	+$5.09K	0.05%	350
2020 Q2	$321K	Buy	5,769 +1,467	+34%	+$62.8K	0.04%	399
2020 Q1	$128K	Sell	4,302 -514	-11%	-$17.4K	0.02%	682
2019 Q4	$174K	Buy	4,816 +27	+0.6%	+$828	0.02%	749
2019 Q3	$130K	Sell	4,789 -231	-5%	-$5.97K	0.01%	826
2019 Q2	$121K	Buy	5,020 +1,810	+56%	+$45.9K	0.01%	842
2019 Q1	$85K	Buy	+3,210	New	+$76.1K	0.02%	584
2017 Q3	–	Sell	-67	Closed	-$1K	–	2013
2017 Q2	$1K	Hold	67	–	–	﹤0.01%	1879
2017 Q1	$1K	Sell	67 -33	-33%	-$534	﹤0.01%	1847
2016 Q4	$2K	Buy	+100	New	+$1.81K	﹤0.01%	2222
2015 Q3	–	Sell	-1,900	Closed	-$66K	–	2013
2015 Q2	$66K	Buy	+1,900	New	+$58K	0.02%	588

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Next Financial Group's HZNP Position: Q4 2021 in Review

Next Financial Group increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 23% in Q4 2021, buying an estimated $145K and bringing the position to 7,243 shares worth $781K. The position accounts for 0.05% of the portfolio, ranked #380.

Next Financial Group first reported a position in HZNP in Q2 2015 and has held it in 16 quarters since. 611 funds tracked by Wall St. Rank hold HZNP as of Q4 2021.

Next Financial Group held 7,243 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $781K as of Q4 2021.
Next Financial Group bought 1,331 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2021, an estimated $145K.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.05% of Next Financial Group's portfolio in Q4 2021, its #380 holding.
Next Financial Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and has held it in 16 quarters since.
611 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.